Skip to main content

Anaplastic Thyroid Cancer

  • Chapter
  • First Online:
Tips and Tricks in Endocrine Surgery

Abstract

Anaplastic, or undifferentiated, thyroid cancer is one of the most aggressive solid tumors with an extremely poor prognosis. It is believed that around 50 % of anaplastic thyroid cancers arise from a prior or coexistent differentiated thyroid carcinoma. The loss of the tumor suppressor gene p53 is an important step in this process.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid. 2000;10(7):587–94.

    Article  PubMed  CAS  Google Scholar 

  • Bhatia A, Rao A, Ang KK, et al. Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy. Head Neck. 2010;32(7):829–36.

    PubMed  Google Scholar 

  • Haigh PI, Ituarte PH, Wu HS, et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer. 2001;91(12):2335–42.

    Article  PubMed  CAS  Google Scholar 

  • Lim SM, Shin SJ, Chung WY, et al. Treatment outcome of patients with anaplastic thyroid cancer: a single center experience. Yonsei Med J. 2012;53(2):352–7.

    Article  PubMed  Google Scholar 

  • Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233–40.

    Article  PubMed  CAS  Google Scholar 

  • Nagaiah G, Hossain A, Mooney CJ, et al. Thyroid cancer: a review of epidemiology pathogenesis, and treatment. J Oncol. 2011;2011:542358.

    Article  PubMed  Google Scholar 

  • Patel KN, Shaha AR. Poorly differentiated and anaplastic thyroid cancer. Cancer Control. 2006;13(2):119–28.

    PubMed  Google Scholar 

  • Tennvall J, Lundell G, Wahlberg P, et al. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer. 2002;86:1848–53.

    Article  PubMed  CAS  Google Scholar 

  • ZYBRESTAT(TM) (CA4P) improves overall survival in a phase 2/3 trial (FACT Study) of patients with Anaplastic Thyroid Cancer (ATC). OXiGENE press release of Phase 2/3 results Sept 2010 posted at http://www.globenewswire.com/newsroom/news.html?d=201261.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Caroline Connolly MBChB, FRCR .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Connolly, C., Glaholm, J. (2014). Anaplastic Thyroid Cancer. In: Watkinson, J., Scott-Coombes, D. (eds) Tips and Tricks in Endocrine Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-2146-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2146-6_17

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-982-6

  • Online ISBN: 978-1-4471-2146-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics